Credit: Celltrion USA. Zymfentra is a subcutaneous formulation of Inflectra, a biosimilar to Remicade. Zymfentra is indicated as maintenance treatment only; all patients must complete an IV induction ...

June 13, 2006 -- The U.S. Food and Drug Administration (FDA) has approved a 2000-IU (5-mL) dose for antihemophilic factor VIII [recombinant] infusion; and an expanded indication for infliximab ...

Please provide your email address to receive an email when new articles are posted on . SEATTLE — Patients with proliferative vitreoretinopathy experienced improved visual acuity after receiving an ...

Avsola (infliximab-axxq) is a prescription drug that’s used to treat certain autoimmune conditions. Avsola can cause side effects that range from mild to serious. Examples include infections and ...

The US Food and Drug Administration (FDA) has approved infliximab-dyyb (Zymfentra, Celltrion USA) for maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) and Crohn ...

Please provide your email address to receive an email when new articles are posted on . No efficacy difference for IBD was found between infliximab-dyyb monotherapy or in combination with ...

Infliximab biosimilars created price competition causing insurance claims costs for infliximab originator and infliximab biosimilars to decrease, generating significant savings to the health care ...

Metro Infusion Center provides safe, affordable, and physician-supervised outpatient infusion and injection therapy at 200+ locations nationwide. Our certified infusion nurses specialize in biologic ...